Self-Assembled Glycopeptide Nanofibers as Modulators of Galectin-1 Bioactivity

Cellular and Molecular Bioengineering

Volumn 8, Issue 3, 2015, Pages 471-487

  Restuccia, Antonietta ^a   Tian, Ye F ^b,c   Collier, Joel H ^b   Hudalla, Gregory A ^a,b  

^a J Crayton Pruitt Family Department of Biomedical Engineering   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Illinois Institute of Technology   (United States)

Author keywords

Galectin; Peptide nanofibers; Protein carbohydrate interactions; Self assembly

Indexed keywords

AMINOSUGAR; ASPARAGINE; BETA 1,4 GALACTOSYLTRANSFERASE; BETA LACTOSE; GALACTOSYLTRANSFERASE; GALECTIN 1; GALECTIN 3; GLYCOPEPTIDE; GLYCOPROTEIN; LACTOSE; N ACETYLGLUCOSAMINE; N ACETYLLACTOSAMINE; NANOFIBER; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOSE;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BETA SHEET; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE;

EID: 84939565040     PISSN: 18655025     EISSN: 18655033     Source Type: Journal    
DOI: 10.1007/s12195-015-0399-2     Document Type: Article

References (83)

1. Aida, T., E. W. Meijer, and S. I. Stupp. Functional supramolecular polymers. Science 335:813–817, 2012.
2. Arikawa, T., A. Matsukawa, K. Watanabe, K. M. Sakata, M. Seki, M. Nagayama, K. Takeshita, K. Ito, T. Niki, S. Oomizu, R. Shinonaga, N. Saita, and M. Hirashima. Galectin-9 accelerates transforming growth factor beta3-induced differentiation of human mesenchymal stem cells to chondrocytes. Bone 44:849–857, 2009.
3. Ban, L., and M. Mrksich. On-chip synthesis and label-free assays of oligosaccharide arrays. Angew. Chem. Int. Edit. 47:3396–3399, 2008.
4. Banh, A., J. Zhang, H. Cao, D. M. Bouley, S. Kwok, C. Kong, A. J. Giaccia, A. C. Koong, and Q. T. Le. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res. 71:4423–4431, 2011.
5. Baum, L. G., D. P. Blackall, S. Arias-Magallano, D. Nanigian, S. Y. Uh, J. M. Browne, D. Hoffmann, C. E. Emmanouilides, M. C. Territo, and G. C. Baldwin. Amelioration of graft versus host disease by galectin-1. Clin. Immunol. 109:295–307, 2003.
6. Baum, L. G., O. B. Garner, K. Schaefer, and B. Lee. Microbe–host interactions are positively and negatively regulated by galectin–glycan interactions. Front. Immunol. 5:284, 2014.
7. Beer, M. V., C. Rech, P. Gasteier, B. Sauerzapfe, J. Salber, A. Ewald, M. Moller, L. Elling, and J. Groll. The next step in biomimetic material design: poly-LacNAc-mediated reversible exposure of extra cellular matrix components. Adv. Healthc. Mater. 2:306–311, 2013.
8. Buskas, T., S. Ingale, and G. J. Boons. Glycopeptides as versatile tools for glycobiology. Glycobiology 16:113R–136R, 2006.
9. Camby, I., M. Le Mercier, F. Lefranc, and R. Kiss. Galectin-1: a small protein with major functions. Glycobiology 16:137R–157R, 2006.
10. Cedeno-Laurent, F., and C. J. Dimitroff. Galectin-1 research in T cell immunity: past, present and future. Clin. Immunol. 142:107–116, 2012.
11. Chan, J., K. O’Donoghue, M. Gavina, Y. Torrente, N. Kennea, H. Mehmet, H. Stewart, D. J. Watt, J. E. Morgan, and N. M. Fisk. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 24:1879–1891, 2006.
12. Chen, J., R. R. Pompano, F. W. Santiago, L. Maillat, R. Sciammas, T. Sun, H. Han, D. J. Topham, A. S. Chong, and J. H. Collier. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. Biomaterials 34:8776–8785, 2013.
13. Collier, J. H., and P. B. Messersmith. Enzymatic modification of self-assembled peptide structures with tissue transglutaminase. Bioconjug. Chem. 14:748–755, 2003.
14. Collier, J. H., J. S. Rudra, J. Z. Gasiorowski, and J. P. Jung. Multi-component extracellular matrices based on peptide self-assembly. Chem. Soc. Rev. 39:3413–3424, 2010.
15. Cortegano, I., V. del Pozo, B. Cardaba, B. de Andres, S. Gallardo, A. del Amo, I. Arrieta, A. Jurado, P. Palomino, F. T. Liu, and C. Lahoz. Galectin-3 down-regulates IL-5 gene expression on different cell types. J. Immunol. 161:385–389, 1998.
16. Du, X., J. Zhou, O. Guvench, F. O. Sangiorgi, X. Li, N. Zhou, and B. Xu. Supramolecular assemblies of a conjugate of nucleobase, amino acids, and saccharide act as agonists for proliferation of embryonic stem cells and development of zygotes. Bioconjug. Chem. 25:1031–1035, 2014.
17. Espelt, M. V., D. O. Croci, M. L. Bacigalupo, P. Carabias, M. Manzi, M. T. Elola, M. C. Munoz, F. P. Dominici, C. Wolfenstein-Todel, G. A. Rabinovich, and M. F. Troncoso. Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. Hepatology 53:2097–2106, 2011.
18. Etulain, J., S. Negrotto, M. V. Tribulatti, D. O. Croci, J. Carabelli, O. Campetella, G. A. Rabinovich, and M. Schattner. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors. PLoS ONE 9:e96402, 2014.
19. Fortuna-Costa, A., A. M. Gomes, E. O. Kozlowski, M. P. Stelling, and M. S. Pavao. Extracellular galectin-3 in tumor progression and metastasis. Front Oncol. 4:138, 2014.
20. Friedrichs, J., A. Manninen, D. J. Muller, and J. Helenius. Galectin-3 regulates integrin alpha2beta1-mediated adhesion to collagen-I and -IV. J. Biol. Chem. 283:32264–32272, 2008.
21. Galan, M. C., P. Dumy, and O. Renaudet. Multivalent glyco(cyclo)peptides. Chem. Soc. Rev. 42:4599–4612, 2013.
22. Galler, K. M., L. Aulisa, K. R. Regan, R. N. D’Souza, and J. D. Hartgerink. Self-assembling multidomain peptide hydrogels: designed susceptibility to enzymatic cleavage allows enhanced cell migration and spreading. J. Am. Chem. Soc. 132:3217–3223, 2010.
23. Garcia, I., A. Sanchez-Iglesias, M. Henriksen-Lacey, M. Grzelczak, S. Penades, and L. M. Liz-Marzan. Glycans as biofunctional ligands for gold nanorods: stability and targeting in protein-rich media. J. Am. Chem. Soc. 137:3686–3692, 2015.
24. Gasiorowski, J. Z., and J. H. Collier. Directed intermixing in multicomponent self-assembling biomaterials. Biomacromolecules 12:3549–3558, 2011.
25. Giano, M. C., D. J. Pochan, and J. P. Schneider. Controlled biodegradation of self-assembling beta-hairpin peptide hydrogels by proteolysis with matrix metalloproteinase-13. Biomaterials 32:6471–6477, 2011.
26. Godula, K., and C. R. Bertozzi. Density variant glycan microarray for evaluating cross-linking of mucin-like glycoconjugates by lectins. J. Am. Chem. Soc. 134:15732–15742, 2012.
27. Goldring, K., G. E. Jones, R. Thiagarajah, and D. J. Watt. The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J. Cell Sci. 115:355–366, 2002.
28. Goldstein, I. J., and R. D. Poretz. Isolation, physicochemical characterization, and carbohydrate-binding specificity of lectins. In: The Lectins: Properties, Functions, and Applications in Biology and Medicine, edited by I. E. Liener, N. Sharon, and I. J. Goldstein. Orlando: Academic Press, 1986, pp. 103–115.
29. Hatano, K., K. Matsuoka, and D. Terunuma. Carbosilane glycodendrimers. Chem. Soc. Rev. 42:4574–4598, 2013.
30. Heusschen, R., A. W. Griffioen, and V. L. Thijssen. Galectin-9 in tumor biology: a jack of multiple trades. Biochim. Biophys. Acta 1836:177–185, 2013.
31. Horiguchi, N., K. Arimoto, A. Mizutani, Y. Endo-Ichikawa, H. Nakada, and S. Taketani. Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells. J. Biochem. 134:869–874, 2003.
32. Horlacher, T., M. A. Oberli, D. B. Werz, L. Krock, S. Bufali, R. Mishra, J. Sobek, K. Simons, M. Hirashima, T. Niki, and P. H. Seeberger. Determination of carbohydrate-binding preferences of human galectins with carbohydrate microarrays. ChemBioChem 11:1563–1573, 2010.
33. Hudalla, G. A., J. A. Modica, Y. F. Tian, J. S. Rudra, A. S. Chong, T. Sun, M. Mrksich, and J. H. Collier. A self-adjuvanting supramolecular vaccine carrying a folded protein antigen. Adv. Healthc. Mater. 2:1114–1119, 2013.
34. Hudalla, G. A., T. Sun, J. Z. Gasiorowski, H. Han, Y. F. Tian, A. S. Chong, and J. H. Collier. Gradated assembly of multiple proteins into supramolecular nanomaterials. Nat. Mater. 13:829–836, 2014.
35. Hughes, R. C. Galectins as modulators of cell adhesion. Biochimie 83:667–676, 2001.
36. Ingrassia, L., I. Camby, F. Lefranc, V. Mathieu, P. Nshimyumukiza, F. Darro, and R. Kiss. Anti-galectin compounds as potential anti-cancer drugs. Curr. Med. Chem. 13:3513–3527, 2006.
37. Ito, K., K. Stannard, E. Gabutero, A. M. Clark, S. Y. Neo, S. Onturk, H. Blanchard, and S. J. Ralph. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment. Cancer Metastasis Rev. 31:763–778, 2012.
38. Jiang, H. R., Z. Al Rasebi, E. Mensah-Brown, A. Shahin, D. Xu, C. S. Goodyear, S. Y. Fukada, F. T. Liu, F. Y. Liew, and M. L. Lukic. Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J. Immunol. 182:1167–1173, 2009.
39. Jung, J. H., M. Amaike, and S. Shinkai. Sol-gel transcription of novel sugar-based superstructures composed of sugar-integrated gelators into silica: creation of a lotus-shaped silica structure. Chem. Commun. 2343–2344, 2000.
40. Jung, J. P., A. K. Nagaraj, E. K. Fox, J. S. Rudra, J. M. Devgun, and J. H. Collier. Co-assembling peptides as defined matrices for endothelial cells. Biomaterials 30:2400–2410, 2009.
41. Kiyonaka, S., K. Sada, I. Yoshimura, S. Shinkai, N. Kato, and I. Hamachi. Semi-wet peptide/protein array using supramolecular hydrogel. Nat. Mater. 3:58–64, 2004.
42. Komatsu, H., S. Matsumoto, S. Tamaru, K. Kaneko, M. Ikeda, and I. Hamachi. Supramolecular hydrogel exhibiting four basic logic gate functions to fine-tune substance release. J. Am. Chem. Soc. 131:5580–5585, 2009.
43. Kuwabara, I., and F. T. Liu. Galectin-3 promotes adhesion of human neutrophils to laminin. J. Immunol. 156:3939–3944, 1996.
44. Leffler, H., S. Carlsson, M. Hedlund, Y. Qian, and F. Poirier. Introduction to galectins. Glycoconj. J. 19:433–440, 2004.
45. Lei, C. X., W. Zhang, J. P. Zhou, and Y. K. Liu. Interactions between galectin-3 and integrinbeta3 in regulating endometrial cell proliferation and adhesion. Hum. Reprod. 24:2879–2889, 2009.
46. Levy, Y., R. Arbel-Goren, Y. R. Hadari, S. Eshhar, D. Ronen, E. Elhanany, B. Geiger, and Y. Zick. Galectin-8 functions as a matricellular modulator of cell adhesion. J. Biol. Chem. 276:31285–31295, 2001.
47. Li, X., Y. Kuang, J. Shi, Y. Gao, H. C. Lin, and B. Xu. Multifunctional, biocompatible supramolecular hydrogelators consist only of nucleobase, amino acid, and glycoside. J. Am. Chem. Soc. 133:17513–17518, 2011.
48. Li, X. M., Y. Kuang, and B. Xu. “Molecular trinity” for soft nanomaterials: integrating nucleobases, amino acids, and glycosides to construct multifunctional hydrogelators. Soft Matter 8:2801–2806, 2012.
49. Loo, Y., S. Zhang, and C. A. Hauser. From short peptides to nanofibers to macromolecular assemblies in biomedicine. Biotechnol. Adv. 30:593–603, 2012.
50. Lundquist, J. J., and E. J. Toone. The cluster glycoside effect. Chem. Rev. 102:555–578, 2002.
51. Martinez, A., C. Ortiz Mellet, and J. M. Garcia Fernandez. Cyclodextrin-based multivalent glycodisplays: covalent and supramolecular conjugates to assess carbohydrate-protein interactions. Chem. Soc. Rev. 42:4746–4773, 2013.
52. Miura, Y. Design and synthesis of well-defined glycopolymers for the control of biological functionalities. Polym. J. 44:679–689, 2012.
53. Moiseeva, E. P., E. L. Spring, J. H. Baron, and D. P. de Bono. Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix. J. Vasc. Res. 36:47–58, 1999.
54. Motran, C. C., K. M. Molinder, S. D. Liu, F. Poirier, and M. C. Miceli. Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function. Eur. J. Immunol. 38:3015–3027, 2008.
55. Nagae, M., N. Nishi, S. Nakamura-Tsuruta, J. Hirabayashi, S. Wakatsuki, and R. Kato. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue. J. Mol. Biol. 375:119–135, 2008.
56. Nagata, Y., and M. B. Burger. Wheat germ agglutinin: molecular characteristics and specificity for sugar binding. J. Biol. Chem. 249:3116–3122, 1974.
57. Oberg, C. T., H. Leffler, and U. J. Nilsson. Inhibition of galectins with small molecules. Chimia (Aarau) 65:18–23, 2011.
58. Pace, K. E., H. P. Hahn, and L. G. Baum. Preparation of recombinant human galectin-1 and use in T-cell death assays. Method Enzymol. 363:499–518, 2003.
59. Pieters, R. J. Inhibition and detection of galectins. ChemBioChem 7:721–728, 2006.
60. Rabinovich, G. A., and M. A. Toscano. Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 9:338–352, 2009.
61. Rabinovich, G. A., M. A. Toscano, S. S. Jackson, and G. R. Vasta. Functions of cell surface galectin-glycoprotein lattices. Curr. Opin. Struct. Biol. 17:513–520, 2007.
62. Ramakrishnan, B., P. S. Shah, and P. K. Qasba. alpha-Lactalbumin (LA) stimulates milk beta-1,4-galactosyltransferase I (beta 4Gal-T1) to transfer glucose from UDP-glucose to N-acetylglucosamine. Crystal structure of beta 4Gal-T1 × LA complex with UDP-Glc. J. Biol. Chem. 276:37665–37671, 2001.
63. Rudra, J. S., Y. F. Tian, J. P. Jung, and J. H. Collier. A self-assembling peptide acting as an immune adjuvant. Proc. Natl. Acad. Sci. USA 107:622–627, 2010.
64. Sansone, F., and A. Casnati. Multivalent glycocalixarenes for recognition of biological macromolecules: glycocalyx mimics capable of multitasking. Chem. Soc. Rev. 42:4623–4639, 2013.
65. Sauerzapfe, B., K. Krenek, J. Schmiedel, W. W. Wakarchuk, H. Pelantova, V. Kren, and L. Elling. Chemo-enzymatic synthesis of poly-N-acetyllactosamine (poly-LacNAc) structures and their characterization for CGL2-galectin-mediated binding of ECM glycoproteins to biomaterial surfaces. Glycoconj. J. 26:141–159, 2009.
66. Schattner, M., and G. A. Rabinovich. Galectins: new agonists of platelet activation. Biol. Chem. 394:857–863, 2013.
67. Shylaja, M., and H. S. Seshadri. Glycoproteins—an overview. Biochem. Educ. 17:170–178, 1989.
68. Solis, D., M. J. Mate, M. Lohr, J. P. Ribeiro, L. Lopez-Merino, S. Andre, E. Buzamet, F. J. Canada, H. Kaltner, M. Lensch, F. M. Ruiz, G. Haroske, U. Wollina, M. Kloor, J. Kopitz, J. L. Saiz, M. Menendez, J. Jimenez-Barbero, A. Romero, and H. J. Gabius. N-domain of human adhesion/growth-regulatory galectin-9: preference for distinct conformers and non-sialylated N-glycans and detection of ligand-induced structural changes in crystal and solution. Int. J. Biochem. Cell Biol. 42:1019–1029, 2010.
69. Stannard, K. A., P. M. Collins, K. Ito, E. M. Sullivan, S. A. Scott, E. Gabutero, I. Darren Grice, P. Low, U. J. Nilsson, H. Leffler, H. Blanchard, and S. J. Ralph. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model. Cancer Lett. 299:95–110, 2010.
70. Stillman, B. N., D. K. Hsu, M. Pang, C. F. Brewer, P. Johnson, F. T. Liu, and L. G. Baum. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J. Immunol. 176:778–789, 2006.
71. Stowell, S. R., C. M. Arthur, P. Mehta, K. A. Slanina, O. Blixt, H. Leffler, D. F. Smith, and R. D. Cummings. Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens. J. Biol. Chem. 283:10109–10123, 2008.
72. Stowell, S. R., Y. Qian, S. Karmakar, N. S. Koyama, M. Dias-Baruffi, H. Leffler, R. P. McEver, and R. D. Cummings. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J. Immunol. 180:3091–3102, 2008.
73. St-Pierre, C., H. Manya, M. Ouellet, G. F. Clark, T. Endo, M. J. Tremblay, and S. Sato. Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4. J. Virol. 85:11742–11751, 2011.
74. Sturm, A., M. Lensch, S. Andre, H. Kaltner, B. Wiedenmann, S. Rosewicz, A. U. Dignass, and H. J. Gabius. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J. Immunol. 173:3825–3837, 2004.
75. Thijssen, V. L., and A. W. Griffioen. Galectin-1 and -9 in angiogenesis: a sweet couple. Glycobiology 24:915–920, 2014.
76. Toscano, M. A., G. A. Bianco, J. M. Ilarregui, D. O. Croci, J. Correale, J. D. Hernandez, N. W. Zwirner, F. Poirier, E. M. Riley, L. G. Baum, and G. A. Rabinovich. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8:825–834, 2007.
77. Tribulatti, M. V., M. G. Figini, J. Carabelli, V. Cattaneo, and O. Campetella. Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses. J. Immunol. 188:2991–2999, 2012.
78. Wan, S. Y., T. F. Zhang, and Y. Ding. Galectin-3 enhances proliferation and angiogenesis of endothelial cells differentiated from bone marrow mesenchymal stem cells. Transplant. Proc. 43:3933–3938, 2011.
79. Woolfson, D. N., and Z. N. Mahmoud. More than just bare scaffolds: towards multi-component and decorated fibrous biomaterials. Chem. Soc. Rev. 39:3464–3479, 2010.
80. Yang, R. Y., D. K. Hsu, L. Yu, H. Y. Chen, and F. T. Liu. Galectin-12 is required for adipogenic signaling and adipocyte differentiation. J. Biol. Chem. 279:29761–29766, 2004.
81. Yang, R. Y., G. A. Rabinovich, and F. T. Liu. Galectins: structure, function and therapeutic potential. Expert Rev. Mol. Med. 10:e17, 2008.
82. Yu, H., H. Chokhawala, R. Karpel, B. Wu, J. Zhang, Y. Zhang, Q. Jia, and X. Chen. A multifunctional Pasteurella multocida sialyltransferase: a powerful tool for the synthesis of sialoside libraries. J. Am. Chem. Soc. 127:17618–17619, 2005.
83. Zhou, M., A. M. Smith, A. K. Das, N. W. Hodson, R. F. Collins, R. V. Ulijn, and J. E. Gough. Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials 30:2523–2530, 2009.